Position in VTGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$83,949
-$174,483 QoQ
Shares Held
365,002
-19.5% QoQ
Ownership
0.823%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 48 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. VTGN ranks #453 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in VTGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $83,949 | 365,002 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $258,432 | 453,391 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $232,871 | 352,836 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,058,893 | 298,280 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $545,814 | 272,907 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $675,467 | 270,187 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $757,931 | 256,926 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $778,156 | 258,524 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,009,526 | 290,094 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,475,664 | 279,482 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,410,786 | 274,472 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $383,379 | 73,164 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $107,192 | 57,322 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $413,976 | 3,449,805 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $327,261 | 3,272,616 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $506,953 | 3,379,691 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,970,416 | 3,375,473 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,002,428 | 3,227,765 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,991,688 | 3,072,661 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $8,435,237 | 3,078,554 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $9,491,605 | 3,013,208 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,208,432 | 1,036,823 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $558,795 | 288,039 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $176,159 | 251,656 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $133,377 | 251,656 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $110,728 | 251,656 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||